sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Category : Pharmaceuticals and Healthcare QY Research Pages :98
Published Date : 2020-06-24

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the At-Home Drug of Abuse Market with our analysts monitoring the situation across the globe.
This report covers market size and forecasts of At-Home Drug of Abuse, including the following market information: Global At-Home Drug of Abuse Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global At-Home Drug of Abuse Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global At-Home Drug of Abuse Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global At-Home Drug of Abuse Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units) Key market players Major competitors identified in this market include Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Drägerwerk, Express Diagnostics, Psychemedics Corporation, Waters Corporation, BioMerieux, Roche, etc. Based on the Region: Asia-Pacific (China, Japan, South Korea, India and ASEAN) North America (US and Canada) Europe (Germany, France, UK and Italy) Rest of World (Latin America, Middle East & Africa) Based on the Type: Consumable Equipment Based on the Application: Urine Saliva Hair Others
1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on At-Home Drug of Abuse Industry 1.7 COVID-19 Impact: At-Home Drug of Abuse Market Trends 2 Global At-Home Drug of Abuse Quarterly Market Size Analysis 2.1 At-Home Drug of Abuse Business Impact Assessment - COVID-19 2.1.1 Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global At-Home Drug of Abuse Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global At-Home Drug of Abuse Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global At-Home Drug of Abuse Factory Price by Manufacturers 3.3 Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into At-Home Drug of Abuse Market 3.5 Key Manufacturers At-Home Drug of Abuse Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on At-Home Drug of Abuse Segments, By Type 4.1 Introduction 1.4.1 Consumable 1.4.2 Equipment 4.2 By Type, Global At-Home Drug of Abuse Market Size, 2019-2021 4.2.1 By Type, Global At-Home Drug of Abuse Market Size by Type, 2020-2021 4.2.2 By Type, Global At-Home Drug of Abuse Price, 2020-2021 5 Impact of Covid-19 on At-Home Drug of Abuse Segments, By Application 5.1 Overview 5.5.1 Urine 5.5.2 Saliva 5.5.3 Hair 5.5.4 Others 5.2 By Application, Global At-Home Drug of Abuse Market Size, 2019-2021 5.2.1 By Application, Global At-Home Drug of Abuse Market Size by Application, 2019-2021 5.2.2 By Application, Global At-Home Drug of Abuse Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Siemens AG 7.1.1 Siemens AG Business Overview 7.1.2 Siemens AG At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.1.3 Siemens AG At-Home Drug of Abuse Product Introduction 7.1.4 Siemens AG Response to COVID-19 and Related Developments 7.2 Danaher Corporation 7.2.1 Danaher Corporation Business Overview 7.2.2 Danaher Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.2.3 Danaher Corporation At-Home Drug of Abuse Product Introduction 7.2.4 Danaher Corporation Response to COVID-19 and Related Developments 7.3 Shimadzu Corporation 7.3.1 Shimadzu Corporation Business Overview 7.3.2 Shimadzu Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.3.3 Shimadzu Corporation At-Home Drug of Abuse Product Introduction 7.3.4 Shimadzu Corporation Response to COVID-19 and Related Developments 7.4 MilliporeSigma 7.4.1 MilliporeSigma Business Overview 7.4.2 MilliporeSigma At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.4.3 MilliporeSigma At-Home Drug of Abuse Product Introduction 7.4.4 MilliporeSigma Response to COVID-19 and Related Developments 7.5 Drägerwerk 7.5.1 Drägerwerk Business Overview 7.5.2 Drägerwerk At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.5.3 Drägerwerk At-Home Drug of Abuse Product Introduction 7.5.4 Drägerwerk Response to COVID-19 and Related Developments 7.6 Express Diagnostics 7.6.1 Express Diagnostics Business Overview 7.6.2 Express Diagnostics At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.6.3 Express Diagnostics At-Home Drug of Abuse Product Introduction 7.6.4 Express Diagnostics Response to COVID-19 and Related Developments 7.7 Psychemedics Corporation 7.7.1 Psychemedics Corporation Business Overview 7.7.2 Psychemedics Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.7.3 Psychemedics Corporation At-Home Drug of Abuse Product Introduction 7.7.4 Psychemedics Corporation Response to COVID-19 and Related Developments 7.8 Waters Corporation 7.8.1 Waters Corporation Business Overview 7.8.2 Waters Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.8.3 Waters Corporation At-Home Drug of Abuse Product Introduction 7.8.4 Waters Corporation Response to COVID-19 and Related Developments 7.9 BioMerieux 7.9.1 BioMerieux Business Overview 7.9.2 BioMerieux At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.9.3 BioMerieux At-Home Drug of Abuse Product Introduction 7.9.4 BioMerieux Response to COVID-19 and Related Developments 7.10 Roche 7.10.1 Roche Business Overview 7.10.2 Roche At-Home Drug of Abuse Quarterly Production and Revenue, 2020 7.10.3 Roche At-Home Drug of Abuse Product Introduction 7.10.4 Roche Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 At-Home Drug of Abuse Supply Chain Analysis 8.1.1 At-Home Drug of Abuse Supply Chain Analysis 8.1.2 Covid-19 Impact on At-Home Drug of Abuse Supply Chain 8.2 Distribution Channels Analysis 8.2.1 At-Home Drug of Abuse Distribution Channels 8.2.2 Covid-19 Impact on At-Home Drug of Abuse Distribution Channels 8.2.3 At-Home Drug of Abuse Distributors 8.3 At-Home Drug of Abuse Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

Get Free Sample

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on At-Home Drug of Abuse Assessment Table 9. COVID-19 Impact: At-Home Drug of Abuse Market Trends Table 10. COVID-19 Impact Global At-Home Drug of Abuse Market Size Table 11. Global At-Home Drug of Abuse Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units) Table 12. Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit) Table 13. Global At-Home Drug of Abuse Quarterly Market Size, 2020 (US$ Million) & (K Units) Table 14. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units) Table 16. Global At-Home Drug of Abuse Market Growth Drivers Table 17. Global At-Home Drug of Abuse Market Restraints Table 18. Global At-Home Drug of Abuse Market Opportunities Table 19. Global At-Home Drug of Abuse Market Challenges Table 20. Key Manufacturers At-Home Drug of Abuse Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, At-Home Drug of Abuse Market Size, 2019 (K Units) & (US$ Million) Table 22. At-Home Drug of Abuse Factory Price by Manufacturers 2020 (USD/Unit) Table 23. Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Plants Table 24. Key Manufacturers At-Home Drug of Abuse Market Served Table 25. Date of Key Manufacturers Enter into At-Home Drug of Abuse Market Table 26. Key Manufacturers At-Home Drug of Abuse Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global At-Home Drug of Abuse Market Size by Type, 2020, (US$ Million) Table 29. Global At-Home Drug of Abuse Market Size by Type, 2020 (K Units) Table 30. Global At-Home Drug of Abuse Price: by Type, 2020-2021 (USD/Unit) Table 31. Global At-Home Drug of Abuse Market Size by Application: 2020-2021 (US$ Million) Table 32. Global At-Home Drug of Abuse Market Size by Application, 2020-2021 (K Units) Table 33. Global At-Home Drug of Abuse Price: by Application, 2020-2021 (USD/Unit) Table 34. Global At-Home Drug of Abuse Market Size by Region, 2019-2021 (US$ Million) Table 35. Global At-Home Drug of Abuse Market Size by Region, 2019-2021 (K Units) Table 36. By Country, North America At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America At-Home Drug of Abuse Market Size, 2019-2021 (K Units) Table 38. US At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 39. Canada At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe At-Home Drug of Abuse Market Size, 2019-2021 (K Units) Table 43. Germany At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 44. France At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 45. UK At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 46. Italy At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific At-Home Drug of Abuse Market Size, 2019-2021 (K Units) Table 50. China At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 51. Japan At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 52. South Korea At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 53. India At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 54. ASEAN At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 55. Latin America At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 56. Middle East and Africa At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units) Table 57. Siemens AG Business Overview Table 58. Siemens AG At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Siemens AG At-Home Drug of Abuse Product Table 60. Siemens AG Response to COVID-19 and Related Developments Table 61. Danaher Corporation Business Overview Table 62. Danaher Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Danaher Corporation At-Home Drug of Abuse Product Table 64. Danaher Corporation Response to COVID-19 and Related Developments Table 65. Shimadzu Corporation Business Overview Table 66. Shimadzu Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Shimadzu Corporation At-Home Drug of Abuse Product Table 68. Shimadzu Corporation Response to COVID-19 and Related Developments Table 69. MilliporeSigma Business Overview Table 70. MilliporeSigma At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. MilliporeSigma At-Home Drug of Abuse Product Table 72. MilliporeSigma Response to COVID-19 and Related Developments Table 73. Drägerwerk Business Overview Table 74. Drägerwerk At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Drägerwerk At-Home Drug of Abuse Product Table 76. Drägerwerk Response to COVID-19 and Related Developments Table 77. Express Diagnostics Business Overview Table 78. Express Diagnostics At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Express Diagnostics At-Home Drug of Abuse Product Table 80. Express Diagnostics Response to COVID-19 and Related Developments Table 81. Psychemedics Corporation Business Overview Table 82. Psychemedics Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Psychemedics Corporation At-Home Drug of Abuse Product Table 84. Psychemedics Corporation Response to COVID-19 and Related Developments Table 85. Waters Corporation Business Overview Table 86. Waters Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Waters Corporation At-Home Drug of Abuse Product Table 88. Waters Corporation Response to COVID-19 and Related Developments Table 89. BioMerieux Business Overview Table 90. BioMerieux At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. BioMerieux At-Home Drug of Abuse Product Table 92. BioMerieux Response to COVID-19 and Related Developments Table 93. Roche Business Overview Table 94. Roche At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Roche At-Home Drug of Abuse Product Table 96. Roche Response to COVID-19 and Related Developments Table 97. At-Home Drug of Abuse Distributors List Table 98. At-Home Drug of Abuse Customers List Table 99. Covid-19 Impact on At-Home Drug of Abuse Customers List of Figures Figure 1. At-Home Drug of Abuse Product Picture Figure 2. At-Home Drug of Abuse Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global At-Home Drug of Abuse Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global At-Home Drug of Abuse Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global At-Home Drug of Abuse Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global At-Home Drug of Abuse Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific At-Home Drug of Abuse Market Size Market Share, 2019-2021

Get Free Sample

Related Reports

Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)